USPTO serial 79141004
ALBIX
Reviewed by CopyMark Law Group
Reg. 4607782Status 404
- Filing date
- Status date
- Registration date
- Sep 23, 2014
- Examiner
- MAKHDOOM, SAIMA
- Law office
- POST REGISTRATION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ALBIX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | [ Chemicals used in industry, science, agriculture, horticulture and forestry except herbicides, fungicides, parasiticides and insecticides; chemicals for use in medicines and in the preparation of pharmaceuticals, namely, excipients for the stabilisation of pharmaceuticals and vaccines; reagents, namely, medium ingredient for the growth of animal cell lines; diagnostic reagents for biochemical analysis; proteins, namely, proteins for industrial use; ] albumin for use in the manufacture of pharmaceuticals, vaccines, medical substances and cell therapy preparations; chemical substances for use in diagnostic kits, namely, albumin blocking agents used to bind to test kit surfaces to prevent non-specific binding of test substances to the surface [ ; chemical substances for use in tissue culture, namely, cell growth media for growing animal cells, stem cells and cell therapy preparations ] | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical products and substances; reagents * for pharmaceutical and medical use * ; diagnostic reagents * for medical use * ; proteins * for pharmaceutical and medical use * ; albumin * for pharmaceutical and medical use * ; recombinant albumin * for pharmaceutical and medical use * ; diagnostic imaging agents | SECTION 71 - CANCELLED | — |
| 042 | Scientific and technological research and development services for new products and uses in the fields of biopharmaceuticals, pharmaceuticals, vaccines, medical devices, cell therapies and stem cells; consultancy services regarding product research and product development in the fields of biopharmaceuticals, pharmaceuticals, vaccines, medical devices, cell therapies, and stem cell research; advisory services with respect to research, development and suitable uses of biopharmaceuticals, pharmaceuticals, vaccines, medical devices, cell therapies and stem cells; providing expert analysis with respect to research, development and suitable uses of biopharmaceuticals, pharmaceuticals, vaccines, medical devices, cell therapies, and stem cells * in the field of development of medicines and pharmaceutical products *; and scientific development and analysis in the fields of pharmaceuticals, vaccines, and drug discoveries; all relating to * the use of albumin in * science, biotechnology, biochemistry, biology, medicine and pharmaceuticals | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Novozymes Biopharma DK A/S
- Other trademarks owned by Novozymes Biopharma DK A/S
- Other trademarks owned by Albumedix Ltd
- Other trademarks owned by Albumedix A/S
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named ALBIX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 6, 2024 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| May 6, 2024 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| May 6, 2024 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Apr 2, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 29, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 4, 2022 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Apr 22, 2022 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Apr 22, 2022 | INPC | INVALIDATION PROCESSED | — |
| Dec 9, 2021 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Apr 23, 2021 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Apr 9, 2021 | C71T | CANCELLED SECTION 71 | — |
| Jan 23, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 23, 2019 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Mar 14, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 24, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 11, 2018 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Feb 1, 2018 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 13, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 9, 2016 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Oct 28, 2016 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Apr 27, 2016 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 28, 2016 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Feb 26, 2016 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 24, 2016 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Feb 19, 2016 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Oct 22, 2015 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 22, 2015 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 20, 2015 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Jul 20, 2015 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Mar 20, 2015 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 27, 2015 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 27, 2015 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 23, 2014 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 19, 2014 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Nov 19, 2014 | PLGL | ASSIGNED TO PARALEGAL | — |
| Nov 19, 2014 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Oct 30, 2014 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Sep 23, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 22, 2014 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 8, 2014 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 8, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 2, 2014 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 2, 2014 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 18, 2014 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 5, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 27, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 27, 2014 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 27, 2014 | ALIE | ASSIGNED TO LIE | — |
| May 26, 2014 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 26, 2014 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 26, 2014 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 22, 2014 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 19, 2014 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 19, 2014 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 3, 2014 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 3, 2014 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 1, 2014 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 31, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 25, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 14, 2014 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 8, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 2, 2014 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |